Speaker: Markus Zeitlinger, Head of Department, Department of Clinical Pharmacology, Medical University of Vienna (Austria)

Moderator: Markus Heep, Medical Lead Zoliflodacin programme, GARDP (Switzerland)

In this webinar, Markus Zeitlinger gave an overview of different goals of phase 1 studies of antibiotic drug development.

Topics discussed included:

  • Combination of several aims in one study
  • What do I need to extrapolate antimicrobial efficacy based on phase 1
  • Most frequent questions during scientific advice

This live webinar including interactive Q&A session was broadcast on 30 June 2020.

If you have questions or comments, please let us know. Do so by submitting them via the ‘Talk to an expert’ feature or contact us by email: revive@gardp.org.